Design Therapeutics clinical trials we track

Check company identity source

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyNCT07024693DT-168Recruiting2027-12Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters